ES2536238T3 - Péptidos antimicrobianos - Google Patents

Péptidos antimicrobianos Download PDF

Info

Publication number
ES2536238T3
ES2536238T3 ES10798035.1T ES10798035T ES2536238T3 ES 2536238 T3 ES2536238 T3 ES 2536238T3 ES 10798035 T ES10798035 T ES 10798035T ES 2536238 T3 ES2536238 T3 ES 2536238T3
Authority
ES
Spain
Prior art keywords
seq
peptide
antimicrobial peptides
antimicrobial
antiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10798035.1T
Other languages
English (en)
Inventor
Aurélie Tasiemski
Michel Salzet
Françoise Gaill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Lille 1 Sciences et Technologies
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite de Lille 1 Sciences et Technologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite de Lille 1 Sciences et Technologies filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of ES2536238T3 publication Critical patent/ES2536238T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Un péptido que comprende o consiste en la SEC ID Nº 1, o un péptido que deriva de la SEC ID Nº 1, que tiene dicho péptido una identidad al menos del 80% con los aminoácidos 1 a 22 de la SEC ID Nº 1, y que tiene una actividad antimicrobiana, antivírica o fungicida, con la condición de que el péptido mencionado anteriormente no consista en las SEC ID Nos 2 a 5.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES10798035.1T 2009-12-21 2010-12-13 Péptidos antimicrobianos Active ES2536238T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09306289 2009-12-21
EP09306289A EP2336155A1 (en) 2009-12-21 2009-12-21 Antimicrobial peptides
PCT/EP2010/069536 WO2011076605A1 (en) 2009-12-21 2010-12-13 Antimicrobial peptides

Publications (1)

Publication Number Publication Date
ES2536238T3 true ES2536238T3 (es) 2015-05-21

Family

ID=42236675

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10798035.1T Active ES2536238T3 (es) 2009-12-21 2010-12-13 Péptidos antimicrobianos

Country Status (5)

Country Link
US (1) US8652514B2 (es)
EP (2) EP2336155A1 (es)
CN (1) CN102741274B (es)
ES (1) ES2536238T3 (es)
WO (1) WO2011076605A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106021999B (zh) * 2016-05-17 2018-02-27 郑州轻工业学院 一种多功能抗微生物肽的最优多标记集成预测方法
NZ748875A (en) 2016-05-27 2022-07-01 Nattocat Llc Compositions and methods for thromboembolism dissolution
CN111253474B (zh) * 2019-10-10 2023-07-07 应连心 一种抗菌肽rg-27及其应用
EP4198045A1 (en) 2021-12-16 2023-06-21 Université de Lille Antimicrobial peptides, variants and chemical analogues thereof and their uses
CN114106103B (zh) * 2022-01-24 2022-04-15 中国科学院南海海洋研究所 一种贝类来源的抗菌肽p-amp108及在制备治疗痤疮药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766191B1 (fr) 1997-07-21 2000-11-10 Ifremer Peptides anti-microbiens de crustaces
US7335759B2 (en) * 2002-12-02 2008-02-26 Universidad Nacional Autónoma de Méxica (UNAM) Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides
RU2512525C2 (ru) * 2005-08-26 2014-04-10 Новозимс Эдениум Байотек А/С Полипептиды, обладающие антимикробной активновностью, и полинуклеотиды, кодирующие их
AU2007325838B2 (en) * 2006-11-22 2013-09-19 Bristol-Myers Squibb Company Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR

Also Published As

Publication number Publication date
CN102741274A (zh) 2012-10-17
CN102741274B (zh) 2014-07-09
EP2336155A1 (en) 2011-06-22
WO2011076605A1 (en) 2011-06-30
US8652514B2 (en) 2014-02-18
EP2516453B1 (en) 2015-02-11
EP2516453A1 (en) 2012-10-31
US20130004564A1 (en) 2013-01-03

Similar Documents

Publication Publication Date Title
ES2619322T3 (es) Agente inductor de inmunidad
ES2512141T3 (es) Análogo peptídico de oxintomodulina
ES2486675T3 (es) Análogo de péptido de oxintomodulina
ES2616658T3 (es) Péptidos que mimetizan el factor de crecimiento y sus usos
ES2652643T3 (es) Péptidos terapéuticos y su uso contra la corea de Huntington
ES2540858T3 (es) Composición farmacéutica para el tratamiento y/o la prevención de cáncer
ES2534752T3 (es) Nuevo péptido antigénico contra el cáncer y utilización del mismo
ES2536238T3 (es) Péptidos antimicrobianos
ES2691070T3 (es) Péptidos antiinflamatorios y composición que comprende los mismos
ES2668967T3 (es) Inmunógenos de Escherichia coli con solubilidad mejorada
ES2691539T3 (es) Luciferasas de Oplophorus sintéticas con mayor emisión de luz
ES2693321T3 (es) Péptidos antiinflamatorios y composición que comprende los mismos
ES2545457T3 (es) Vacunas de péptidos para cánceres que expresan los polipéptidos DEPDC1
ES2524251T3 (es) Proteínas de tipo interferón humano recombinantes
CR20150196A (es) Moléculas de unión il-17a novedosas y usos médicos de las mismas
AR067980A1 (es) Peptidos de cdh3 y agentes que los comprenden
AR083126A1 (es) Composicion vacunal para el control de las infestaciones por ectoparasitos
FI3737399T3 (fi) ATF5-peptidivariantit ja niiden käytöt
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
ES2527454T3 (es) El uso de derivados del péptido Wnt5-a para el tratamiento de melanoma y cáncer gástrico
ES2666001T3 (es) Variantes de proteasa mejoradas en cuanto al rendimiento
ES2570458T3 (es) Peptidomiméticos fijados sobre una matriz con actividad moduladora de CXCR7
ES2533697T3 (es) Inhibidores peptídicos para mediar respuestas de estrés
ES2551697T3 (es) Protección de péptidos contra toxicidad por luz ultravioleta
ES2605171T3 (es) Composiciones ansiolíticas que comprenden péptidos derivados de la Caseína ALFAs1